Holen Sie sich die Stockscreener-App
4.72
3.28%
-0.16
Schlusskurs vom Vortag:
$4.88
Offen:
$4.91
24-Stunden-Volumen:
776.97K
Relative Volume:
0.43
Marktkapitalisierung:
$454.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.49M
KGV:
-5.8344
EPS:
-0.809
Netto-Cashflow:
$-73.48M
1W Leistung:
-5.41%
1M Leistung:
-9.23%
6M Leistung:
+41.32%
1J Leistung:
-20.67%
1-Tages-Spanne:
$4.545
$4.91
1-Wochen-Bereich:
$4.545
$5.13
52-Wochen-Spanne:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Firmenname
Rezolute Inc
Sektor
Branche
Telefon
650-206-4507
Adresse
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
4.72 | 475.68M | 0 | -81.49M | -73.48M | -0.809 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-25 | Hochstufung | Wedbush | Neutral → Outperform |
| 2025-12-11 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-11-05 | Eingeleitet | Wedbush | Outperform |
| 2024-08-27 | Eingeleitet | Guggenheim | Buy |
| 2024-07-17 | Eingeleitet | BTIG Research | Buy |
| 2024-06-04 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-09 | Eingeleitet | Maxim Group | Buy |
| 2022-08-02 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-27 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
RZLT|Rezolute Inc|Price:4.930|Chg%:-0.060 - TradingKey
RZLT|Rezolute Inc|Price:4.990| - TradingKey
Rezolute Inc (RZLT) Balance Sheet - TradingKey
Rezolute Inc (RZLT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rezolute Inc (RZLT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rezolute Inc (RZLT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rezolute Inc (RZLT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rezolute Inc (RZLT) Institutional Confidence - TradingKey
Rezolute Inc (RZLT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rezolute Inc (RZLT) Income Statement - TradingKey
Rezolute Inc (RZLT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rezolute Inc (RZLT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rezolute to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times
Rezolute Management to Meet Investors Online July 28-29 - Stock Titan
Rezolute (RZLT) Q2 2026 Earnings: EPS Beat with 12.33% Surprise Amid No RevenuePeak Earnings Alert - dars.gov.et
Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans? - Moomoo
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Rezolute Inc. (RZLT) Edges Higher Amid Positive Momentum, Testing Key ResistanceBollinger Expansion - dars.gov.et
Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar - simplywall.st
Rezolute (RZLT) CMO disposes 3,062 shares in mandated RSU tax sale - Stock Titan
Form 4 Rezolute Inc For: 7 July By Investing.com - Investing.com Nigeria
Rezolute (RZLT) CEO logs automatic RSU tax-withholding share sale in Form 4 - Stock Titan
Rezolute (RZLT) CFO logs RSU tax sell-to-cover, retains 411,400 shares - Stock Titan
RZLTRezolute Inc Options - Finviz
RZLT News | REZOLUTE INC (NASDAQ:RZLT) - ChartMill
Price to earnings forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to book forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to earnings forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to revenue forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Enterprise value to revenue forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to EBITDA forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to EBIT forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to sales forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Enterprise value to EBIT forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Price to sales forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Rezolute, Inc. Actuals & Estimates (NASDAQ:RZLT) - TradingView
RZLT Forecast — Price Target — Prediction for 2027 - TradingView
A Quick Look at Today's Ratings for Rezolute(RZLT.US), With a Forecast Between $5 to $14 - Moomoo
Rezolute Inc (RZLT) Valuation: PE, PB & Fair Value Analysis - TradingKey
RZLT stock plummets 79% month to date: Here's what you need to know - MSN
RZLT Q1 2026 Earnings: EPS Beats Estimates Amid Ongoing Clinical DevelopmentHigh Growth Earnings - dars.gov.et
Rezolute's Ersodetug Advances in Rare Hypoglycemia Treatment Amid Pharma Growth - Streetwise Reports
Biopharma Developer Unveils Breakthrough Hypoglycemia Treatment Data - Streetwise Reports
Rezolute data: 75% of tumor HI patients came off IV dextrose at ENDO - Stock Titan
Rezolute presents hyperinsulinism data at endocrine meeting - Investing.com UK
Rezolute presents hyperinsulinism data at endocrine meeting By Investing.com - Investing.com South Africa
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society - The Manila Times
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug ... - Caledonian Record
Finanzdaten der Rezolute Inc-Aktie (RZLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rezolute Inc-Aktie (RZLT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hogenhuis Wladimir | Director |
Dec 16 '25 |
Buy |
1.69 |
5,650 |
9,548 |
119,675 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Dec 16 '25 |
Buy |
1.70 |
28,000 |
47,600 |
308,352 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.77 |
40,000 |
70,640 |
415,900 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.79 |
5,000 |
8,938 |
7,000 |
| Elam Nevan C | CEO |
Dec 15 '25 |
Buy |
1.59 |
32,000 |
50,880 |
641,119 |
| Karnawat Sunil Ratilal | Chief Commercial Officer |
Dec 15 '25 |
Buy |
1.62 |
12,100 |
19,599 |
71,542 |
| Evans Daron | CFO |
Dec 09 '25 |
Buy |
5.04 |
10,549 |
53,167 |
131,900 |
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):